English
This article is from Heart Views : The Official Journal of the Gulf Heart Association , volume 14 . Abstract Introduction:: Ivabradine is a novel selective If current inhibitor with anti-ischemic and antianginal activity. Objectives:: To assess the effect of the selective If current inhibitor ivabradine on heart rate, angina pectoris, and functional capacity in stable patients with chronic coronary artery disease on maximally tolerated medical therapy. Materials and Methods:: Consecutive patients from the out-patient cardiology clinic with stable coronary artery disease documented by coronary angiography were included. Patients had to be on maximally tolerated medical therapy with β-blockers, angiotensin-converting enzyme inhibitors or receptor blockers (ACE-I or ARB), antiplatelets, statins, nitrates, and anti-metabolics with a baseline heart rate of at least 70 beats per minute. All patients underwent assessment of angina (Canadian Cardiovascular Society Angina Class: CCS I to IV) and functional capacity (using a validated self-administered questionnaire), at baseline and after 4 months of ivabradine therapy. Results:: Twenty patients were enrolled (mean age 47 ± 7 years, all mal
Sign in with your free account to read, download EPUBs or listen.
Ebook · Short-Term Effects of Ivabradine in Patients with Chronic Stable Ischemic Heart Disease. · Zaky, Hosam, Elzein, Hind, Alsheikh-Ali, Alawi A., Al-Mulla, Arif · Internet Archive